ACTRN12614001234606CompletedPhase 4
Assessing the potential for silver dressings to enhance healing of diabetes-related foot ulcers.
Conditions
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Sponsor
- The Royal Melbourne Hospital
- Enrollment
- 176
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomised controlled trial
- Primary Purpose
- Treatment
- Masking
- Blinded (masking used)
Eligibility Criteria
- Ages
- 18 Years to o limit (—)
- Sex
- All
Inclusion Criteria
- •Participants will need to have a confirmed diagnosis of diabetes and an ulcer distal to the level of the ankle. The ulcer will be of less than 6 weeks duration at the time of recruitment and participants will be 18 years or older.
Exclusion Criteria
- •Individuals who are pregnant, who have an allergy to silver, Mepilex or Zetuvit, wounds with tendons or underlying osteomyelitis and individuals with a life expectancy of less than 12 weeks will be excluded from the study.
Investigators
Similar Trials
Not yet recruiting
Phase 3
The effect of hydrocolloid dressing in the treatment of skin graft woundsIRCT20220302054168N1Iran University of Medical Sciences30
Recruiting
Unknown
To determine the efficacy of negative pressure wound therapy (NPWT) in promoting wound healing of diabetic foot ulcer.CTRI/2024/07/070984I
Active, not recruiting
Phase 2
Evaluation of the effectiveness of an ionic silver dressing on a burn victimBurnsRBR-97v22nwFaculdade de medicina de Ribeirão Preto
Completed
Not Applicable
the effect of dressing on the infection rate of hemodialysis catheters in hemodialysis patientshemodialysis patients.Dependence on renal dialysisZ99.2IRCT20210412050938N1Oroumia University of Medical Sciences120
Not yet recruiting
Phase 2
Evaluating the effectiveness of silver spray in sclerodermascleroderma.Systemic sclerosis [scleroderma]IRCT20191221045837N5Mashhad University of Medical Sciences50